| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc. | President and CEO, Director | Restricted Stock Units | 169K | $357K | $3.96 | Aug 14, 2025 | Direct |
| Solid Biosciences Inc. | President and CEO, Director | Common Stock | 60.7K | $240K | $3.96 | Feb 14, 2025 | Direct |
| Solid Biosciences Inc. | President and CEO, Director | Employee Stock Option (Right to Buy) | 338K | Aug 14, 2025 | Direct | ||
| Vor Biopharma Inc. | Director | Stock Option (right to buy) | 60K | Jul 16, 2025 | Direct | ||
| Climb Bio, Inc. | Director | Stock Option (Right to Buy) | 40K | Jun 4, 2025 | Direct | ||
| Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Jul 25, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Aug 14, 2025 | 2 | $0 | 4 | Aug 18, 2025 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jul 25, 2025 | 2 | $0 | 4 | Jul 28, 2025 | Director |
| VOR | Vor Biopharma Inc. | Jul 16, 2025 | 1 | $0 | 4 | Jul 18, 2025 | Director |
| VOR | Vor Biopharma Inc. | Jul 16, 2025 | 0 | $0 | 3 | Jul 18, 2025 | Director |
| VERV | Verve Therapeutics, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director |
| CLYM | Climb Bio, Inc. | Jun 4, 2025 | 1 | $0 | 4 | Jun 5, 2025 | Director |
| CLYM | Climb Bio, Inc. | Mar 28, 2025 | 1 | $0 | 4 | Apr 1, 2025 | Director |
| CLYM | Climb Bio, Inc. | Mar 28, 2025 | 0 | $0 | 3 | Apr 1, 2025 | Director |
| SLDB | Solid Biosciences Inc. | Feb 13, 2025 | 3 | -$45K | 4 | Feb 18, 2025 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Jan 31, 2025 | 1 | $0 | 4 | Feb 11, 2025 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2024 | 3 | -$62.2K | 4 | Dec 4, 2024 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
| SLDB | Solid Biosciences Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 16, 2024 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2023 | 3 | -$32.5K | 4 | Dec 5, 2023 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 3 | $0 | 4 | Dec 5, 2022 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 0 | $0 | 3 | Dec 5, 2022 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 0 | $0 | 3 | Jun 13, 2022 | Director |